Regulation of monocyte interleukin-12 production by acute alcohol: A role for inhibition by interleukin-10

Linda Girouard, Pranoti Mandrekar, Donna Catalano, G. Szabó

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Acute ethanol treatment results in decreased antigen presentation capacity (Th1-type immunity) and elevated interleukin IL-10 (Th2 cytokine) production in human monocytes. Monocytes can contribute to both Th1 (IL-12) and Th2 (IL-10) immune responses via production of IL-12 and IL-10, respectively. Thus, we tested the hypothesis that acute alcohol treatment might affect Th1/Th2 immune balance by altering monocyte production of IL-12 and IL-10. Neither acute ethanol treatment alone (25 to 100 mM) nor its combination with a bacterial challenge Staphylococcal enterotoxin B (SEB) induced IL-12 production in isolated blood monocytes. In contrast, the same physiological alcohol concentrations increased monocyte IL-10 levels, suggesting that ethanol can induce a dysbalance of monocyte-derived mediator production at the expense of Th1 cytokines. However, we found that monocyte activation with interferon-γ (IFN-γ) can prevent the preferential IL-10 induction by ethanol. IFN-γ (100 units/ml) inhibited monocyte IL-10 production whether induced by 1 μg/ml of lipopolysaccharide (p < 0.01), 1 μg/ml of SEB (p < 0.02), or a combination of bacterial stimulation + ethanol (lipopolysaccharide: p < 0.01). Furthermore, decreased IL-10 was concomitant to an increase in IL-12 production in IFN-γ-treated monocytes. Moreover, acute ethanol treatment augmented IL-12 production in IFN-γ-treated monocytes in response to SEB stimulation (25 mM ethanol, p < 0.01; 100 mM ethanol, p < 0.01). Experiments with anti-IL-10 neutralizing antibody show that ethanol may prevent monocyte IL-12 induction via IL-10. These results suggest that inhibition of ethanol-induced IL-10 production by IFN-γ treatment is permissive for IL-12 induction by alcohol stimulation in monocytes. Thus, our results imply that the presence or absence of IFN-γ is critical in determining the effect of acute ethanol treatment on monocyte IL- 12 versus IL-10 induction.

Original languageEnglish
Pages (from-to)211-216
Number of pages6
JournalAlcoholism: Clinical and Experimental Research
Volume22
Issue number1
Publication statusPublished - Feb 1998

Fingerprint

Interleukin-12
Interleukin-10
Monocytes
Alcohols
Ethanol
Interferons
Lipopolysaccharides
Cytokines
Th1-Th2 Balance
Interleukins
Neutralizing Antibodies
Antigen Presentation
Blood
Immunity
Chemical activation
Antigens

Keywords

  • Ethanol
  • Interferon-γ
  • Macrophages
  • Th1/Th2 immune response

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Toxicology

Cite this

Regulation of monocyte interleukin-12 production by acute alcohol : A role for inhibition by interleukin-10. / Girouard, Linda; Mandrekar, Pranoti; Catalano, Donna; Szabó, G.

In: Alcoholism: Clinical and Experimental Research, Vol. 22, No. 1, 02.1998, p. 211-216.

Research output: Contribution to journalArticle

@article{0282b01b01b84a4aad4128b5103759cd,
title = "Regulation of monocyte interleukin-12 production by acute alcohol: A role for inhibition by interleukin-10",
abstract = "Acute ethanol treatment results in decreased antigen presentation capacity (Th1-type immunity) and elevated interleukin IL-10 (Th2 cytokine) production in human monocytes. Monocytes can contribute to both Th1 (IL-12) and Th2 (IL-10) immune responses via production of IL-12 and IL-10, respectively. Thus, we tested the hypothesis that acute alcohol treatment might affect Th1/Th2 immune balance by altering monocyte production of IL-12 and IL-10. Neither acute ethanol treatment alone (25 to 100 mM) nor its combination with a bacterial challenge Staphylococcal enterotoxin B (SEB) induced IL-12 production in isolated blood monocytes. In contrast, the same physiological alcohol concentrations increased monocyte IL-10 levels, suggesting that ethanol can induce a dysbalance of monocyte-derived mediator production at the expense of Th1 cytokines. However, we found that monocyte activation with interferon-γ (IFN-γ) can prevent the preferential IL-10 induction by ethanol. IFN-γ (100 units/ml) inhibited monocyte IL-10 production whether induced by 1 μg/ml of lipopolysaccharide (p < 0.01), 1 μg/ml of SEB (p < 0.02), or a combination of bacterial stimulation + ethanol (lipopolysaccharide: p < 0.01). Furthermore, decreased IL-10 was concomitant to an increase in IL-12 production in IFN-γ-treated monocytes. Moreover, acute ethanol treatment augmented IL-12 production in IFN-γ-treated monocytes in response to SEB stimulation (25 mM ethanol, p < 0.01; 100 mM ethanol, p < 0.01). Experiments with anti-IL-10 neutralizing antibody show that ethanol may prevent monocyte IL-12 induction via IL-10. These results suggest that inhibition of ethanol-induced IL-10 production by IFN-γ treatment is permissive for IL-12 induction by alcohol stimulation in monocytes. Thus, our results imply that the presence or absence of IFN-γ is critical in determining the effect of acute ethanol treatment on monocyte IL- 12 versus IL-10 induction.",
keywords = "Ethanol, Interferon-γ, Macrophages, Th1/Th2 immune response",
author = "Linda Girouard and Pranoti Mandrekar and Donna Catalano and G. Szab{\'o}",
year = "1998",
month = "2",
language = "English",
volume = "22",
pages = "211--216",
journal = "Alcoholism: Clinical and Experimental Research",
issn = "0145-6008",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Regulation of monocyte interleukin-12 production by acute alcohol

T2 - A role for inhibition by interleukin-10

AU - Girouard, Linda

AU - Mandrekar, Pranoti

AU - Catalano, Donna

AU - Szabó, G.

PY - 1998/2

Y1 - 1998/2

N2 - Acute ethanol treatment results in decreased antigen presentation capacity (Th1-type immunity) and elevated interleukin IL-10 (Th2 cytokine) production in human monocytes. Monocytes can contribute to both Th1 (IL-12) and Th2 (IL-10) immune responses via production of IL-12 and IL-10, respectively. Thus, we tested the hypothesis that acute alcohol treatment might affect Th1/Th2 immune balance by altering monocyte production of IL-12 and IL-10. Neither acute ethanol treatment alone (25 to 100 mM) nor its combination with a bacterial challenge Staphylococcal enterotoxin B (SEB) induced IL-12 production in isolated blood monocytes. In contrast, the same physiological alcohol concentrations increased monocyte IL-10 levels, suggesting that ethanol can induce a dysbalance of monocyte-derived mediator production at the expense of Th1 cytokines. However, we found that monocyte activation with interferon-γ (IFN-γ) can prevent the preferential IL-10 induction by ethanol. IFN-γ (100 units/ml) inhibited monocyte IL-10 production whether induced by 1 μg/ml of lipopolysaccharide (p < 0.01), 1 μg/ml of SEB (p < 0.02), or a combination of bacterial stimulation + ethanol (lipopolysaccharide: p < 0.01). Furthermore, decreased IL-10 was concomitant to an increase in IL-12 production in IFN-γ-treated monocytes. Moreover, acute ethanol treatment augmented IL-12 production in IFN-γ-treated monocytes in response to SEB stimulation (25 mM ethanol, p < 0.01; 100 mM ethanol, p < 0.01). Experiments with anti-IL-10 neutralizing antibody show that ethanol may prevent monocyte IL-12 induction via IL-10. These results suggest that inhibition of ethanol-induced IL-10 production by IFN-γ treatment is permissive for IL-12 induction by alcohol stimulation in monocytes. Thus, our results imply that the presence or absence of IFN-γ is critical in determining the effect of acute ethanol treatment on monocyte IL- 12 versus IL-10 induction.

AB - Acute ethanol treatment results in decreased antigen presentation capacity (Th1-type immunity) and elevated interleukin IL-10 (Th2 cytokine) production in human monocytes. Monocytes can contribute to both Th1 (IL-12) and Th2 (IL-10) immune responses via production of IL-12 and IL-10, respectively. Thus, we tested the hypothesis that acute alcohol treatment might affect Th1/Th2 immune balance by altering monocyte production of IL-12 and IL-10. Neither acute ethanol treatment alone (25 to 100 mM) nor its combination with a bacterial challenge Staphylococcal enterotoxin B (SEB) induced IL-12 production in isolated blood monocytes. In contrast, the same physiological alcohol concentrations increased monocyte IL-10 levels, suggesting that ethanol can induce a dysbalance of monocyte-derived mediator production at the expense of Th1 cytokines. However, we found that monocyte activation with interferon-γ (IFN-γ) can prevent the preferential IL-10 induction by ethanol. IFN-γ (100 units/ml) inhibited monocyte IL-10 production whether induced by 1 μg/ml of lipopolysaccharide (p < 0.01), 1 μg/ml of SEB (p < 0.02), or a combination of bacterial stimulation + ethanol (lipopolysaccharide: p < 0.01). Furthermore, decreased IL-10 was concomitant to an increase in IL-12 production in IFN-γ-treated monocytes. Moreover, acute ethanol treatment augmented IL-12 production in IFN-γ-treated monocytes in response to SEB stimulation (25 mM ethanol, p < 0.01; 100 mM ethanol, p < 0.01). Experiments with anti-IL-10 neutralizing antibody show that ethanol may prevent monocyte IL-12 induction via IL-10. These results suggest that inhibition of ethanol-induced IL-10 production by IFN-γ treatment is permissive for IL-12 induction by alcohol stimulation in monocytes. Thus, our results imply that the presence or absence of IFN-γ is critical in determining the effect of acute ethanol treatment on monocyte IL- 12 versus IL-10 induction.

KW - Ethanol

KW - Interferon-γ

KW - Macrophages

KW - Th1/Th2 immune response

UR - http://www.scopus.com/inward/record.url?scp=0031909192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031909192&partnerID=8YFLogxK

M3 - Article

C2 - 9514309

AN - SCOPUS:0031909192

VL - 22

SP - 211

EP - 216

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

SN - 0145-6008

IS - 1

ER -